Please wait a minute...
Frontiers of Economics in China

ISSN 1673-3444

ISSN 1673-3568(Online)

CN 11-5744/F

Postal Subscription Code 80-978

Front. Econ. China    2017, Vol. 12 Issue (4) : 607-634    https://doi.org/10.3868/s060-006-017-0025-1
Orginal Article |
Can a Government Initiate Enterprise Reform to Improve Efficiency? A Cross-Section Analysis of the Chinese Pharmaceutical Industry
Ying Chu Ng1(), Suthathip Yaisawarng2
1. Department of Economics, Hong Kong Baptist University, Hong Kong, China
2. Department of Economics, Union College, Schenectady, NY 12308-2311, USA
 Download: PDF(4456 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

This paper examines the effects of state-owned enterprises (SOE) privatization, implemented by the Chinese government in the 1990s, on enterprise efficiency for a sample of non-privatized SOEs and privatized ex-SOEs. The study calculates input-oriented DEA meta-frontier efficiency scores, after accounting for heterogeneity in technology across groups. These scores are used to test whether or not one group’s technology dominates the other. A measure of additional input saving is also provided if these enterprises have access to unrestricted meta-technology. The analysis of the Chinese pharmaceutical industry reveals that privatization has not improved enterprise efficiency, at least in the short run. Almost 56% of inputs could be proportionally saved if these privatized ex-SOEs had been efficient, relative to the meta-production technology while non-privatized SOEs could proportionally save only 51%. Privatized ex-SOEs had less ability to access to meta-technology. This finding could be explained by subsequent observations that China, at the time of our analysis, did not have well-established intellectual property rights and formal drug approval procedures; these two factors are important driving forces for developing joint ventures with foreign investors to gain additional capital funding and technology transfer. Broadly speaking, our results are consistent with the subsequent shakeup in the Chinese pharmaceutical industry.

Keywords privatization      DEA      managerial efficiency      heterogeneous technology      Chinese pharmaceutical enterprises     
Issue Date: 08 December 2017
 Cite this article:   
Ying Chu Ng,Suthathip Yaisawarng. Can a Government Initiate Enterprise Reform to Improve Efficiency? A Cross-Section Analysis of the Chinese Pharmaceutical Industry[J]. Front. Econ. China, 2017, 12(4): 607-634.
 URL:  
http://academic.hep.com.cn/fec/EN/10.3868/s060-006-017-0025-1
http://academic.hep.com.cn/fec/EN/Y2017/V12/I4/607
[1] Saku Aura, Francis K. Cheung, Shawn Ni. Why Doesn’t the Hong Kong Government Sell More Public Land?[J]. Front. Econ. China, 2016, 11(3): 367-389.
[2] Wenjun Liu, Shuliang Zou. Does Openness Increase the Efficiency of China’s Manufacturing Firms? Evidence from the World Bank Investment Climate Survey[J]. Front Econ Chin, 2013, 8(3): 430-451.
[3] Bo Chen, Hong Ma. Trade Restrictiveness and Deadweight Loss in China’s Imports[J]. Front Econ Chin, 2012, 7(3): 478-494.
[4] Yue Shen, Youjun Xu, Jingming Hao. Strategic Incentive in Mixed Oligopoly[J]. Front Econ Chin, 2011, 6(2): 311-326.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed